IFF to Highlight Comprehensive Clean-label Portfolio at Vitafoods Europe 2024
IFF to Highlight Comprehensive Clean-label Portfolio at Vitafoods Europe 2024
PR Newswire
NEW YORK, May 2, 2024
IFF Pharma Solutions and IFF Health to address in-demand topics including plant-based, oral dosage formulation trends, menopause and healthy aging with advanced nutritional innovation and cutting-edge solutions
NEW YORK, May 2, 2024 /PRNewswire/ -- IFF, a global leader in food and beverage, home and personal care and health, will introduce its full suite of plant-based and cellulosic-derived solutions for dietary supplements and over-the-counter (OTC) drugs at Vitafoods Europe 2024. This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.
Designed with precision and expertise, these solutions are tailored to meet the diverse needs of manufacturers, focusing on plant-based formulations, clean-label ingredients, purity, and consistent quality.
"Our plant-based ingredients are meeting the rising demand for clean-label products," said Dr. Michael Baumann, marketing manager, Pharma Solutions, IFF. "From creating aesthetically pleasing tablets to developing high-quality and efficacious immediate release and enteric coatings, our solutions are backed by sound science to address health-conscious consumer demands."
Visitors can learn more about IFF's key pharmaceutical offerings, including:
- Tablets and Capsules: High-performance cellulose-based ingredients, binders and disintegrants including Avicel®, Endurance®, METHOCEL™ and Ac-Di-Sol® enable consumer-friendly formats for nutritional supplements and OTC products. Specific low nitrite grades are also available.
- Release Solutions: The versatile METHOCEL™ family of water-soluble cellulose ethers enhances efficacy for both immediate and controlled release formulations, and is ideal for plant-based hard-shell capsules, coating, granulation, and tablets.
- Clean-Label Coatings: A groundbreaking study that demonstrates successful implementation of GRINDSTED® pectin into traditional tablet coating processes. Aquateric® N100, a delayed-release, alginate-based coating system ensures optimal nutrient delivery.
- Vegan Softgel Technology: Superior vegan soft capsule technologies, including SeaGel® and VERDIGEL™ SC, outperform competing technologies and animal-based counterparts, maintaining structural integrity throughout the product life cycle, enabling higher production rates and better capsule yield.
- Plant-Based Gummies: Hydrocolloid and gummy expertise using Gelcarin® and GRINDSTED® Pectin PRM enables the development of heat-stable, highly efficient gelatin-free gummies with superior sensory experience, stability, processing, and delivery.
At the booth, IFF Health, a business unit from IFF's Health & Biosciences, will also spotlight its range of efficacious, science-backed offerings for women's health and skin health. Visitors can attend the keynote discussion, "Menopause: The untapped market opportunity" hosted by Ben Milhau, EMEA marketing lead, IFF and Heather Jackson, GenM cofounder on Wednesday, May 15, 11.40 a.m. to 12.10 p.m.
IFF Health will launch its Healthy Aging campaign "Free to age, your way" with its initial portfolio of premium quality probiotics and ingredients for all life stages. The campaign's "Build, Maintain, Enjoy" key consumer segments encourages brand owners to partner with IFF to expand their consumer base across areas like like digestion, metabolism, joint and bladder health.
Visit here to learn more about IFF Health and register here to schedule a meeting with IFF's Pharma Solutions experts.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partner with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Contact:
Reena Chaudhary
Global Communications Manager
+91 9769820494
reena.chaudhary@iff.com
SOURCE IFF
-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now